No risk reduction for plasmodium vivax malaria in sickle cell disease

Authors

Bushra Moiz, Aga Khan UniversityFollow
Ayesha Majeed Memon, Aga Khan UniversityFollow

Document Type

Report

Department

Pathology and Laboratory Medicine

Abstract

Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be observed even with hemoglobin S.

Publication (Name of Journal)

Clinical case reports

Recommended Citation

Moiz, B., Memon, A. M. (2018). No risk reduction for plasmodium vivax malaria in sickle cell disease. Clinical case reports, 6(6), 1187-1188.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/729

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.